Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines

Biochemical Pharmacology

Volumn 57, Issue 4, 1999, Pages 407-415

  Van Moorsel, Catharina J A ^a   Pinedo, Herbert M ^a   Veerman, Gijsbert ^a   Guechev, Assen ^a   Smid, Kees ^a   Loves, Willem J P ^a   Vermorken, Jan B ^a   Postmus, Pieter E ^a,b   Peters, Godefridus J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

DNA damage; DNA strand breaks; Etoposide; Gemcitabine; Schedule dependency; Synergism

Indexed keywords

CISPLATIN; ETOPOSIDE; GEMCITABINE; NUCLEOTIDE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; DRUG RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DEOXYCYTOSINE NUCLEOTIDES; DNA DAMAGE; DRUG SYNERGISM; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032928854     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00316-5     Document Type: Article

References (25)

1. Hertel L.W., Kroin J.S., Misner J.W., Tustin J.M. Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2-difluoro-D-ribofuranosyl nucleosides. J Org Chem. 53:1988;2406-2409.
2. Van Moorsel C.J.A., Peters G.J., Pinedo H.M. Gemcitabine Future prospects of single agent and combination studies . Oncologist. 2:1997;127-134.
3. Huang P., Chubb S., Hertel L.W., Grindey G.B., Plunkett W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res. 51:1991;6110-6117.
4. Heinemann V., Hertel L.W., Grindey G.B., Plunkett W. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-β-D-arabinofuranosylcytosine. Cancer Res. 48:1988;4024-4031.
5. Robinson M.I., Osheroff N. Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs Inhibition of enzyme-mediated DNA religation by 4′-(9-acridinylamino)methane-sulfon-m-anisidide . Biochemistry. 29:1990;2511-2515.
6. Dombernowsky P., Nissen I. Combination chemotherapy with 4′-demethyl-epipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside) VP-16-213 (NSC 141540) in L1210 leukemia. Eur J Cancer. 12:1976;181-188.
7. Bergman A.M., Ruiz van Haperen V.W.T., Veerman G., Kuiper C.M., Peters G.J. Interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res. 2:1996;521-530.
8. Ooi K., Ohkubo T., Higashigawa H., Kawasaki H., Sakurai M. Increased deoxycytidine kinase activity by etoposide in L1210 murine leukemic cells. Biol Pharm Bull. 19:1996;1382-1383.
9. Ruiz van Haperen V.W.T., Veerman G., Boven E., Noordhuis P., Vermorken J.B., Peters G.J. Schedule-dependence of sensitivity to 2′-2′-difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumor cell lines and solid tumors. Biochem Pharmacol. 48:1994;1327-1339.
10. Lu Y., Han J., Scanlon K.J. Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid. J Biol Chem. 263:1988;4891-4894.
11. Peters G.J., Wets M., Keepers Y.P.A.M., Oskam R., Van Ark-Otte J., Noordhuis P., Smid K., Pinedo H.M. Transformation of mouse fibroblasts with the oncogenes H-ras or trk is associated with pronounced changes in drug sensitivity and metabolism. Int J Cancer. 54:1993;450-455.
12. Keepers Y.P., Pizao P.E., Peters G.J., Van Ark-Otte J., Winograd B. Comparison of the sulphoramide B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer. 27:1991;897-900.
13. Chou T.C., Talalay P. Quantitative analysis of dose-effect relationship The combined effects of multiple drugs on enzyme inhibitors . Weber G. Advances in Enzyme Regulation. 1983;27-55 Pergamon Press, New York.
14. Greco W.R., Bravo G., Parsons J.C. The search for synergy A critical review from a response surface perspective . Pharmacol Rev. 47:1995;331-385.
15. Hunting D., Henderson J.F. Determination of deoxyribonucleoside triphosphates using DNA polymerase A critical evaluation . Can J Biochem. 59:1981;723-727.
16. Peters GJ, De Abreu RA, Oosterhof A and Veerkamp JH, Concentration of nucleotides and deoxynucleotides in peripheral and phytohemagglutinin-stimulated mammalian lymphocytes. Biochim Biophys Acta 759: 7-15, 1983.
17. Sherman P.A., Fyfe J.A. Enzymatic assay for deoxyribonucleotide triphosphates using synthetic oligonucleotides as template primers. Anal Biochem. 180:1989;222-226.
18. Iwasaki H., Huang P., Keating M.J., Plunkett W. Differential incorporation of AraC, gemcitabine and fludarabine into replicating and repairing DNA in proliferating human leukemia cells. Blood. 90:1997;270-278.
19. Van der Wilt C.L., Visser G.W.M., Braakhuis B.J.M., Wedzinga R., Noordhuis P., Smid K., Peters G.J. In vitro antitumour activity of cis- and trans-5-fluoro-5,6-dihydro-6-alkoxy-ura-cils; effects on thymidylate synthesis. Br J Cancer. 68:1993;702-707.
20. Birnboim H.C., Jevcak J.J. Fluorometic method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation. Cancer Res. 41:1981;1889-1892.
21. Sasvári-Székely M, Csapó Z, Spasokoukotskaja T, Eriksson S and Staub M, Activation of deoxycytidine kinase during inhibition of DNA synthesis in human lymphocytes. Clin Biochem 30: 36 [abstract 147], 1997.
22. Van Moorsel C.J.A., Veerman G., Bergman A.M., Guechev A., Vermorken J.B., Postmus P.E., Peters G.J. Combination chemotherapy studies with gemcitabine. Semin Oncol. 24:(Suppl 7):1997;17-23.
23. Heinemann V., Xu Y.-Z., Chubb S., Sen A., Hertel L.W., Grindey G.B., Plunkett W. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol Pharmacology. 38:1990;567-572.
24. Baker C.H., Banzon J., Bollinger J.M., Stubbe J. 2′-deoxy-2′-methylenecytidine and 2′-deoxy-2′,2′-difluorocytidine 5′-diphosphates potent mechanism-based inhibitors of ribonucleotide reductase . J Med Chem. 34:1991;1879-1884.
25. Robinson M.I., Osheroff N. Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs inhibition of enzyme-mediated DNA religation by 4′-(9-acridinylamino)methane-sulfon-m-anisidide . Biochemistry. 29:1990;2511-2515.